Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 3 |
Nike
NKE
|
+$1.17B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$922M |
| 5 |
Hewlett Packard
HPE
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.13B |
| 3 |
Broadcom
AVGO
|
+$625M |
| 4 |
UnitedHealth
UNH
|
+$584M |
| 5 |
Mastercard
MA
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Healthcare | 7.41% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
PUT
Marqeta
MQ
$1.75B
| $206K | ﹤0.01% |
+12,500
| New | +$197K |
|
5577
Foghorn Therapeutics
FHTX
$323M
| $206K | ﹤0.01% |
56,332
-18,324
| -25% | -$83.5K |
|
5578
Strawberry Fields REIT
STRW
$192M
| $205K | ﹤0.01% |
17,182
+2,104
| +14% | +$24.3K |
|
5579
Destination XL Group
DXLG
$31M
| $204K | ﹤0.01% |
139,799
-27,506
| -16% | -$64.3K |
|
5580
Civeo
CVEO
$324M
| $204K | ﹤0.01% |
+8,858
| New | +$207K |
|
5581
Sanara MedTech
SMTI
$313M
| $203K | ﹤0.01% |
6,581
-5,751
| -47% | -$195K |
|
5582
BlackRock Science and Technology Trust
BST
$1.68B
| $203K | ﹤0.01% |
6,147
+600
| +11% | +$21.9K |
|
5583
Dimensional US Marketwide Value ETF
DFUV
$15.7B
| $202K | ﹤0.01% |
+4,901
| New | +$206K |
|
|
MRSN
5584
DELISTED
Mersana Therapeutics
MRSN
| $202K | ﹤0.01% |
23,466
-8,629
| -27% | -$133K |
|
|
UPB
5585
Upstream Bio Inc
UPB
$367M
| $202K | ﹤0.01% |
32,955
-11,535
| -26% | -$110K |
|
5586
Kyverna Therapeutics
KYTX
$474M
| $202K | ﹤0.01% |
104,460
-9,014
| -8% | -$26.6K |
|
5587
Champions Oncology
CSBR
$72.4M
| $201K | ﹤0.01% |
+23,129
| New | +$234K |
|
5588
Century Casinos
CNTY
$33.5M
| $199K | ﹤0.01% |
117,594
+30,998
| +36% | +$84.2K |
|
5589
Genasys
GNSS
$79.2M
| $198K | ﹤0.01% |
87,213
+46,452
| +114% | +$129K |
|
5590
Alto Ingredients
ALTO
$349M
| $198K | ﹤0.01% |
173,619
-500,795
| -74% | -$775K |
|
|
GOCO
5591
DELISTED
GoHealth
GOCO
| $197K | ﹤0.01% |
16,081
-95
| -0.6% | -$1.45K |
|
5592
Empire Petroleum
EP
$103M
| $195K | ﹤0.01% |
31,004
-3,526
| -10% | -$22.6K |
|
|
NOVA
5593
DELISTED
Sunnova Energy
NOVA
| $194K | ﹤0.01% |
522,801
-1,574,529
| -75% | -$3.03M |
|
5594
Lyell Immunopharma
LYEL
$355M
| $193K | ﹤0.01% |
17,930
-13,436
| -43% | -$165K |
|
5595
AbCellera Biologics
ABCL
$1.95B
| $193K | ﹤0.01% |
86,483
-213,330
| -71% | -$612K |
|
5596
TORM
TRMD
$3B
| $191K | ﹤0.01% |
11,613
-215,693
| -95% | -$4.17M |
|
5597
The ONE Group
STKS
$54M
| $191K | ﹤0.01% |
63,971
-23,824
| -27% | -$75K |
|
5598
ProKidney
PROK
$337M
| $191K | ﹤0.01% |
217,969
-74,027
| -25% | -$103K |
|
|
HQH
5599
abrdn Healthcare Investors
HQH
$1.31B
| $191K | ﹤0.01% |
11,732
+788
| +7% | +$13.5K |
|
|
ZBIO
5600
Zenas BioPharma
ZBIO
$2.02B
| $189K | ﹤0.01% |
23,957
-18,217
| -43% | -$143K |
|
Similar funds
Goldman Sachs's Q1 2025 Portfolio in Review
As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs's Q1 2025 filing shows 547 new, 2,373 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
- Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
- Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
- Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
- Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
- Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.